WecLac® Strains
Clinically Studied
SCI/Patent Supported

Home > Products > WecLac® Strains > Lacticaseibacillus paracasei

Lacticaseibacillus paracaseiLC86

Potency

600B CFU/g


Source of Strain

Handmade yogurt


Deposit Number

PTA-126816(ATCC) No.1.12731(CGMCC)

Functions
  • Gastrointestinal Health
  • Metabolic Health
  • Emotional Health
  • Maternal & Child Health
  • Immune Health
  • Oral Health
References

[1]Dong Y, Han M, Fei T, Liu H, Gai Z. Utilization of diverse oligosaccharides for growth by Bifidobacterium and Lactobacillus species and their in vitro co-cultivation characteristics. Int Microbiol. 2023 Nov 9. doi: 10.1007/s10123-023-00446-x. Epub ahead of print. PMID: 37946011.

[2]Rui W, Zhong S, Li X, Tang X, Wang L, Yang J. Evaluating the Role of Postbiotics in the Modulation of Human Oral Microbiota: A Randomized Controlled Clinical Trial. Probiotics Antimicrob Proteins. 2024 Mar 19. doi: 10.1007/s12602-024-10238-y. Epub ahead of print. PMID: 38502383.

[3]Cai Y, Dong Y, Han M, Jin M, Liu H, Gai Z, Zou K. Lacticaseibacillus paracasei LC86 mitigates age-related muscle wasting and cognitive impairment in SAMP8 mice through gut microbiota modulation and the regulation of serum inflammatory factors. Front Nutr. 2024 May 30;11:1390433. doi: 10.3389/fnut.2024.1390433. PMID: 38873561; PMCID: PMC11169942.

[4]Application of Lactobacillus paracasei in the preparation of products to alleviate anxiety and depression symptoms(ZL 202210409422.9)

Introduction

Diarrhea apparent efficiency

In a randomized, double-blind, placebo-controlled trial of children with diarhea, the tested children were randomly divided into BLa80 probiotic intervention group and control group. After 72 hours of intervention, The marked and total effective rates of the lG were significantly higher than those of the CG.

Subjects

Dosage: Bifidobacterium lactis BLa80.5x109 CFU/sachet.2g/sachet

ltemsIG(n=58)cG(n=53)valuesP values
No. of marked31(53.4)10(18.9)
efficiency[n(% )]*
No.of normal18(31.0)14(26.4)21.6<0.001< /td>
efficiency[n(%)]*<< /td>
No. of inefficiency[n(%)]*9(15.6)29(54.7)
No.of total efficiency[n(%)]*49(84.4)124(45.3)18.901<0.001< /td>
In BLa80 group, the pathological changesof crypt injury, infiltration, ulcer and edema of colonic epithelium were alleviated
Specialization Advantages
  • 40,000+ Strain Resources
  • GRAS certified
  • Allergen free
  • SCI / Patent supported
  • High survivability
  • Non-GMO verified
  • Clinically studied
  • High colonisation
  • Precise function
Industrialization Advantages
  • High potency
  • Low water activity
  • Cost-effectiveness
  • High stability
  • Fast delivery
  • cGMP standard
  • Excellent batch stability
  • Stable supply chain
  • Advanced equipment
Application
  • Dietary Supplement
  • Food
  • Dairy
  • Precision Medicine
  • Personal Care
  • Feed Additive/Pet
No. 999, Guangming Rd., Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province, China
Online Message